In this analysis of laboratory correlates of SARS-CoV-2 seropositivity among patients on dialysis, we find that after accounting for community burden of COVID-19, patients with poorer health status (as reflected by lower serum concentrations of creatinine, albumin, and hemoglobin) have higher likelihood of SARS-CoV-2 antibody. This evidence concerns the gene ALB and COVID-19.